HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shotaro Nakamura Selected Research

Proton Pump Inhibitors

11/2021Lifestyle- and comorbidity-related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan.
2/2021Protective effect of proton pump inhibitors and potassium competitive acid blockers against post-gastric endoscopic submucosal dissection bleeding: a single-center, propensity score-matched analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shotaro Nakamura Research Topics

Disease

11Neoplasms (Cancer)
02/2022 - 04/2005
10Ulcerative Colitis
02/2021 - 02/2002
9Hemorrhage
04/2022 - 08/2006
9Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2022 - 08/2005
9Lymphoma (Lymphomas)
04/2018 - 11/2005
6Crohn Disease (Crohn's Disease)
01/2019 - 12/2005
5Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 08/2015
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2021 - 11/2005
5Myocardial Infarction
10/2017 - 08/2015
5Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
05/2015 - 02/2002
4Ulcer
01/2019 - 08/2006
4Genetic Translocation (Chromosomal Translocation)
01/2016 - 05/2008
3Stomach Neoplasms (Stomach Cancer)
02/2021 - 04/2005
3Pathologic Constriction (Stenosis)
05/2019 - 08/2006
3Colitis
11/2018 - 07/2002
3Death (Near-Death Experience)
10/2017 - 08/2015
3Thrombosis (Thrombus)
11/2016 - 08/2015
3Neoplasm Metastasis (Metastasis)
06/2015 - 04/2005
2Esophagitis
11/2021 - 03/2016
2Adenocarcinoma
12/2020 - 04/2005
2Adenoma (Adenomas)
01/2020 - 01/2006
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 08/2016
2Arthritis (Polyarthritis)
01/2019 - 08/2005
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2018 - 09/2009
2Peptic Ulcer (Peptic Ulcers)
09/2017 - 01/2015
2Hepatocellular Carcinoma (Hepatoma)
06/2015 - 04/2005
1Diverticular Diseases
04/2022
1Immunoproliferative Small Intestinal Disease
01/2022
1Epstein-Barr Virus Infections
01/2022
1Chronic Renal Insufficiency
01/2022
1Inflammation (Inflammations)
11/2021
1Purpura
02/2021
1Abdominal Pain (Pain, Abdominal)
02/2021
1IgA Vasculitis (Purpura, Schoenlein Henoch)
02/2021
1Gastrointestinal Hemorrhage (Hematochezia)
02/2021
1Acute Kidney Injury (Acute Renal Failure)
05/2020
1Diarrhea
05/2020
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1Atherosclerotic Plaque (Atheroma)
01/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
04/2016
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
03/2016

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2002
5omega-Chloroacetophenone (Mace)IBA
06/2022 - 08/2015
5Infliximab (Remicade)FDA Link
02/2021 - 01/2015
4Pharmaceutical PreparationsIBA
02/2021 - 01/2006
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2006
3MucinsIBA
09/2021 - 01/2018
3Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2016 - 05/2008
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2015 - 08/2006
3Capsules (Microcapsules)IBA
01/2013 - 07/2008
2Fibrinolytic Agents (Antithrombotic Agents)IBA
04/2022 - 01/2015
2Immunosuppressive Agents (Immunosuppressants)IBA
02/2022 - 01/2022
2Monoclonal AntibodiesIBA
11/2021 - 12/2017
2Proton Pump InhibitorsIBA
11/2021 - 02/2021
2Gentian Violet (Violet, Crystal)FDA Link
11/2020 - 01/2018
2Indigo Carmine (Indigo Blue)IBA
08/2019 - 11/2018
2AntibodiesIBA
03/2016 - 04/2005
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2015 - 06/2014
2Messenger RNA (mRNA)IBA
11/2005 - 04/2005
1Mechanistic Target of Rapamycin Complex 1IBA
02/2022
1CalciumIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1PotassiumIBA
02/2021
1AcidsIBA
02/2021
1CollagenIBA
12/2020
1VancomycinFDA LinkGeneric
05/2020
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
05/2020
1Immune Checkpoint InhibitorsIBA
05/2020
1Heparin (Liquaemin)FDA LinkGeneric
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1AnticoagulantsIBA
01/2020
1Methotrexate (Mexate)FDA LinkGeneric
06/2019
1Ustekinumab (CNTO 1275)FDA Link
01/2019
1Organic Anion TransportersIBA
01/2019
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
10/2018
1Rituximab (Mabthera)FDA Link
04/2018
1Rabeprazole (Aciphex)FDA Link
04/2018
1Advanced Glycation End ProductsIBA
01/2018
1Syntex adjuvant formulationIBA
01/2018
1LipidsIBA
12/2017
1Coloring Agents (Dyes)IBA
12/2017
1Perilipin-2IBA
12/2017
1NivolumabIBA
01/2017
1XenonIBA
08/2016
1IntegrinsIBA
04/2016

Therapy/Procedure

16Therapeutics
04/2022 - 08/2005
4Drug Therapy (Chemotherapy)
01/2022 - 02/2002
4Stents
05/2019 - 08/2015
3Percutaneous Coronary Intervention
01/2022 - 03/2016
3Radiotherapy
04/2018 - 01/2013
2Endoscopic Hemostasis
09/2017 - 05/2014
2Enteral Nutrition (Feeding, Tube)
10/2006 - 12/2005
1Critical Care (Surgical Intensive Care)
05/2020
1Bridge Therapy
01/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2019
1Gastrectomy
04/2018
1Drug-Eluting Stents
12/2016
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2016